Cramer's Morning Take: Novo Nordisk 7/29/25

SPEAKER_1 (0:00)

Fidelity Trading Dashboard brings live data, news and charts into one screen. Because better trading starts with finding what you need, fast.

SPEAKER_2 (0:07)

Available for free at fidelity.com/tradingdashboard.

Jim Cramer (0:10)

Investing involves risk, including risk of loss. Fidelity Brokerage Services, LLC.

SPEAKER_1 (0:13)

Member NYSE, SIPC.

SPEAKER_2 (0:17)

On WhatsApp, no one can see or hear your personal messages, whether it's a voice call, message or sending a password. To WhatsApp, it's all just this. So, whether you're sharing the streaming password in the family chat or trading those late night voice messages that could basically become a podcast, your personal messages stay between you, your friends and your family. No one else, not even us. WhatsApp, message privately.

Jim Cramer (0:49)

I'm Jim Cramer and you're about to hear a sample taken directly from today's CNBC Investing Club Morning Meeting. Look, everything could be pulled down because it's a little surprise to see so much down. I mean, you've got stocks that are, like, that we didn't think would be down, Whirlpool's down. We got Stanley Black and Decker down. But, you know, a lot of stocks that are just kind of all over the place versus a handful of techs that are doing very well. But maybe the market can stay buy educated. I don't know. I think this is one of the swing modes, maybe the drug stocks, which are very weak.

Jeff Marks (1:23)

Well, let's bring up the drug stocks today because a lot of them are lower. The biggest mover to the downside is Novo Nordisk. This comes after the company slashed its full year outlook. The company cited the use of compound GLP-1, slower than expected market expansion, and competition for Wigovie in the United States. You do have Lilly shares down in sympathy to the results. Some of this makes sense. I think maybe some concern about GLP-1s, though Lilly really hasn't really been a loser from that as much as Novo Nordisk. The slower than the market expansion is negative. Lilly is taking share from Novo, so I think that's clear. But we did trim the position today.

Jim Cramer (2:06)

First of all, where it is? Oh, it's just back to where it was last week.

Jeff Marks (2:08)

Yeah. Really, it's just we just want to make sure, you know, there's something, there really isn't a big slowdown happening in GLP-1s. We don't want to get caught with that from what we're hearing from Novo today.

Jim Cramer (2:21)

We just want Novo to start some sort of price war, which would be capable of anything.

Jeff Marks (2:24)

That's a good point too. Yeah, I mean, that's a really good point too, because that agreement with Novo and CVS to be the primary formulary, that came out the last time Lilly reported. That really crushed the stock, Eli Lilly. So, yes, concern about price.

Jim Cramer (2:43)

We always sell something, we buy back in the morning. Start your day with my outlook on the daily market every morning at 10, 20 a.m. Visit cnbc.com/morningtake to access all the benefits of being a CNBC Investing Club member.

SPEAKER_1 (3:01)

All opinions expressed by Jim Cramer on this podcast and in connection with the CNBC Investing Club are solely Cramer's opinions and do not reflect the opinions of CNBC, NBC Universal or their parent company or affiliates and may have been previously disseminated by Cramer on television, radio, internet or another medium. No specific outcome or profit is guaranteed in connection with your reliance upon or other use of the content from Cramer. The opinions offered in connection with this podcast and the CNBC Investing Club are not an attempt to induce any particular trading behavior, investment or strategy. You should be aware of the risk of loss in following any strategy or investment discussed in the content from Cramer. To view the full CNBC Investing Club Disclaimer, please visit cnbc.com/investingclubdisclaimer.

SPEAKER_5 (3:45)

Is it time to reimagine your future? The right business skills may make a difference in your career. At Capella University, we offer a relevant education that's designed to focus on what you need to know in the business world. We'll teach professional skills to help you pursue your goals, like business management, strategic planning and effective communication. And you can apply these skills right away. A different future is closer than you think with Capella University. Learn more at capella.edu.